Options Brief: Edwards Lifesciences Corporation

Shares of Edwards Lifesciences Corporation EW are higher on the session by 0.02%, trading at $86.03. Overall put volume is now running at 5.55x the daily average, with 37% of all puts traded being purchases on the offer. 1,403 contracts have traded on the session so far. Edwards Lifesciences Corporation is a global player in products and technologies designed to treat advanced cardiovascular disease. The company is focused specifically on technologies that treat structural heart disease and critically ill patients.